|
|
|
Volumn 11, Issue 4, 1997, Pages 290-291
|
|
Clinical trial results of GEM91 show activity against advance HIV.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
ANTISENSE OLIGONUCLEOTIDE;
NUCLEOTIDE;
TRECOVIRSEN;
VIRUS RNA;
ARTICLE;
BLOOD;
DRUG EFFECT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
ANTI-HIV AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
HIV INFECTIONS;
HIV-1;
HUMANS;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
OLIGONUCLEOTIDES, ANTISENSE;
RNA, VIRAL;
THIONUCLEOTIDES;
|
|
EID: 0031201227
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|